OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
7
Results
Show all
Save search
Copy query
Show results for
Unknown
(7)
Publication Date
Release Date
2023
(2)
2025
(1)
2024
(1)
2016
(1)
2013
(1)
2012
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib.
Not available
S-EPMC4980567
|
biostudies-literature
Cite
An in vitro platform for quantifying cell cycle phase lengths in primary human intestinal epithelial cells.
Not available
S-EPMC11219882
|
biostudies-literature
Cite
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer.
Not available
S-EPMC3413275
|
biostudies-literature
Cite
Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.
Not available
S-EPMC4878082
|
biostudies-literature
Cite
A leaky human colon model reveals uncoupled apical/basal cytotoxicity in early
Clostridioides difficile
toxin exposure.
Not available
S-EPMC10010926
|
biostudies-literature
Cite
A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials.
Not available
S-EPMC12568921
|
biostudies-literature
Cite
Life-Threatening Complications of Influenza vs Coronavirus Disease 2019 (COVID-19) in US Children.
Not available
S-EPMC9384330
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets